A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)
Clinical trial NCT02953678 · COMPLETED
Trial details
- NCT number
- NCT02953678
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2018-01-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.